Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse

por Domingo-Domenech, J, Mellado, B, Ferrer, B, Truan, D, Codony-Servat, J, Sauleda, S, Alcover, J, Campo, E, Gascon, P, Rovira, A, Ross, J S, Fernández, P L, Albanell, J
Publicado 2005

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced soli...

por Siegel-Lakhai, W S, Crul, M, Zhang, S, Sparidans, R W, Pluim, D, Howes, A, Solanki, B, Beijnen, J H, Schellens, J H M
Publicado 2005

Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts

por Larsson, S C, Permert, J, Håkansson, N, Näslund, I, Bergkvist, L, Wolk, A
Publicado 2005

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer

por Hackshaw, A, Knight, A, Barrett-Lee, P, Leonard, R
Publicado 2005

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis

por Hardee, M E, Kirkpatrick, J P, Shan, S, Snyder, S A, Vujaskovic, Z, Rabbani, Z N, Dewhirst, M W, Blackwell, K L
Publicado 2005

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical researc...

por Mead, G M, Cullen, M H, Huddart, R, Harper, P, Rustin, G J S, Cook, P A, Stenning, S P, Mason, M
Publicado 2005

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

por Ko, A H, Hwang, J, Venook, A P, Abbruzzese, J L, Bergsland, E K, Tempero, M A
Publicado 2005

p53 immunodetection of liquid-based processed urinary samples helps to identify bladder tumours with a higher risk of progression

por Piaton, E, Faÿnel, J, Ruffion, A, Lopez, J G, Perrin, P, Devonec, M
Publicado 2005

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

por Di Costanzo, F, Carlini, P, Doni, L, Massidda, B, Mattioli, R, Iop, A, Barletta, E, Moscetti, L, Recchia, F, Tralongo, P, Gasperoni, S
Publicado 2005

Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells

por Bocci, G, Fioravanti, A, Orlandi, P, Bernardini, N, Collecchi, P, Del Tacca, M, Danesi, R
Publicado 2005

Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison

por Soo, K-C, Tan, E-H, Wee, J, Lim, D, Tai, B-C, Khoo, M-L, Goh, C, Leong, S-S, Tan, T, Fong, K-W, Lu, P, See, A, Machin, D
Publicado 2005

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

por Schmidt, H, Bastholt, L, Geertsen, P, Christensen, I J, Larsen, S, Gehl, J, von der Maase, H
Publicado 2005

Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer

por Ord, J J, Streeter, E H, Roberts, I S D, Cranston, D, Harris, A L
Publicado 2005

Adenovirus-mediated interferon α gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer

por Ohashi, M, Yoshida, K, Kushida, M, Miura, Y, Ohnami, S, Ikarashi, Y, Kitade, Y, Yoshida, T, Aoki, K
Publicado 2005

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interfe...

por Ota, H, Nagano, H, Sakon, M, Eguchi, H, Kondo, M, Yamamoto, T, Nakamura, M, Damdinsuren, B, Wada, H, Marubashi, S, Miyamoto, A, Dono, K, Umeshita, K, Nakamori, S, Wakasa, K, Monden, M
Publicado 2005

Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer

por Poikonen, P, Sjöström, J, Amini, R-M, Villman, K, Ahlgren, J, Blomqvist, C
Publicado 2005

Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC)

por Lahmann, P H, Schulz, M, Hoffmann, K, Boeing, H, Tjønneland, A, Olsen, A, Overvad, K, Key, T J, Allen, N E, Khaw, K-T, Bingham, S, Berglund, G, Wirfält, E, Berrino, F, Krogh, V, Trichopoulou, A, Lagiou, P, Trichopoulos, D, Kaaks, R, Riboli, E
Publicado 2005

The effect of spiritual healing on in vitro tumour cell proliferation and viability – an experimental study

por Zachariae, R, Højgaard, L, Zachariae, C, Væth, M, Bang, B, Skov, L
Publicado 2005

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

por Chong, G, Dickson, J L B, Cunningham, D, Norman, A R, Rao, S, Hill, M E, Price, T J, Oates, J, Tebbutt, N
Publicado 2005

Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer

por Arigami, T, Natsugoe, S, Uenosono, Y, Arima, H, Mataki, Y, Ehi, K, Yanagida, S, Ishigami, S, Hokita, S, Aikou, T
Publicado 2005